| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $1.76 In Line |
| EPS GAAP Actual | $1.76 In Line |
| Revenue Actual | $0.363711B |
| Revenue Surprise | Beat by $363.711M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 7.805 | 4.29 | 7.72726 | 7.95548 | 1 |
| Dec 2025 | 4.53752 | 7.39 | 4.40153 | 4.7699 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.09 | -0.09 | 0.363711B | 2.79% | 363.71M |
| FQ2 2025 (Jun 2025) | 0.63 | 0.63 | 0.352209B | 8.92% | 352.21M |
| FQ1 2025 (Mar 2025) | 0.57 | 0.57 | 0.328636B | 4.31% | 328.64M |
| FQ4 2024 (Dec 2024) | 1.51 | 1.51 | 0.412823B | 5.56% | 412.82M |
| FQ3 2024 (Sep 2024) | -1.11 | -1.11 | 0.35358B | 3.56% | 353.58M |
| FQ2 2024 (Jun 2024) | 0.81 | 0.81 | 0.3208B | -1.63% | 320.8M |
| FQ1 2024 (Mar 2024) | 0.23 | 0.23 | 0.314485B | 2.33% | 314.49M |
| FQ4 2023 (Dec 2023) | 0.0012 | 0.0012 | 0.389885B | -1.75% | 389.89M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.22634 | -- | 3.12616 | 3.29012 | 1 |
| FQ3 2027 (Sep 2027) | 2.01557 | -- | 1.95298 | 2.05542 | 1 |
| FQ2 2027 (Jun 2027) | 1.64606 | -- | 1.59495 | 1.6786 | 1 |
| FQ1 2027 (Mar 2027) | 1.44628 | -- | 1.40137 | 1.47487 | 1 |
| FQ4 2026 (Oct 2026) | 1.73438 | -- | 1.71683 | 1.75634 | 1 |
| FQ3 2026 (Jul 2026) | 1.58445 | 105.68 | 1.56842 | 1.60451 | 1 |
| FQ2 2026 (Jun 2026) | 1.58445 | 60.24 | 1.55541 | 1.61064 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.46B | -- | 0.45B | 0.46B | 2 |
| FQ3 2027 (Sep 2027) | 0.39B | -- | 0.38B | 0.4B | 2 |
| FQ2 2027 (Jun 2027) | 0.38B | -- | 0.37B | 0.39B | 2 |
| FQ1 2027 (Mar 2027) | 0.35B | -- | 0.35B | 0.36B | 2 |
| FQ4 2026 (Oct 2026) | 0.4B | -- | 0.4B | 0.41B | 2 |
| FQ3 2026 (Jul 2026) | 0.38B | 4.52 | 0.38B | 0.38B | 2 |
| FQ2 2026 (Jun 2026) | 0.38B | 7.54 | 0.38B | 0.39B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.09 | -0.09 | 100% | |
| FQ2 2025 (Jun 2025) | 0.63 | 0.63 | 100% | |
| FQ1 2025 (Mar 2025) | 0.57 | 0.57 | 100% | |
| FQ4 2024 (Dec 2024) | 1.51 | 1.51 | 100% | |
| FQ3 2024 (Sep 2024) | -1.11 | -1.11 | 100% | |
| FQ2 2024 (Jun 2024) | 0.81 | 0.81 | 100% | |
| FQ1 2024 (Mar 2024) | 0.23 | 0.23 | 100% | |
| FQ4 2023 (Dec 2023) | 0.0012 | 0.0012 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.36B | $363.71M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.35B | $352.21M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.33B | $328.64M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.41B | $412.82M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.35B | $353.58M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.32B | $320.8M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.31B | $314.49M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.39B | $389.89M | 100% |